References
- Abbadie, C., Lindia, J. A., Cumiskey, A. M., Peterson, L. B., Mudgett, J. S., Bayne, E. K., DeMartino, J. A., Maclntyre, D. E., Forrest, M. J. (2003). Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2. Proc. Natl. Acad. Sci. USA, 100(13), 7947-7952.
- Badley, A. D., Roumier, T., Lum, J. J., Kroemer, G. (2003). Mitochondrion-mediated apoptosis in HIV-1 infection. Trends Pharmacol. Sci., 24(6), 298-305.
- Baumann, N., Pham-Dinh, D. (2001). Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol. Rev., 81(2), 871-927.
- Bellasio, S., Nicolussi, E., Bertorelli, R., Reggiani, A. (2003). Melanocortin receptor agonists and antagonists modulate nociceptive sensitivity in the mouse formalin test. Eur. J. Pharmacol., 482(1-3), 127-132.
- Benbrik, E., Chariot, P., Bonavaud, S., Ammi-Said, M., Frisdal, E., Rey, C., Gherardi, R., Barlovatz-Meimon, G. (1997). Cellular and mitochondrial toxicity of zidovudine (AZT), didanosine (ddI) and zalcitabine (ddC) on cultured human muscle cells. J. Neurol. Sci., 149(1), 19-25.
- Capone, F., Aloisi, A. M. (2004). Refinement of pain evaluation techniques. The formalin test. Ann. Ist. Super. Sanitą., 40(2), 223-229.
- Cherry, C. L., Skolasky, R. L., Lal, L., Creighton, J., Hauer, P., Raman, S. P., Moore, R., Carter, K., Thomas, D., Ebenezer, G. J., Wesselingh, S. L., McArthur, J. C. (2006). Antiretroviral use and other risks for HIV-associated neuropathies in an international cohort. Neurology, 66(6), 867-873.
- Collins, M. L., Sondel, N., Cesar, D., Hellerstein, M. K. (2004). Effect of nucleoside reverse transcriptase inhibitors on mitochondrial DNA synthesis in rats and humans. J. Acquir. Immune Defic. Syndr., 37(1), 1132-1139.
- Cui, L., Locatelli, L., Xie, M. Y., Sommadossi, J. P. (1997). Effect of nucleoside analogs on neurite regeneration and mitochondrial DNA synthesis in PC-12 cells. J. Pharmacol. Exp. Ther., 280(3), 1228-1234.
- Dambrova, M., Liepinsh, E., Kalvinsh, I. (2002). Mildronate: Cardioprotective action through carnitine-lowering effect. Trends Cardiovasc. Med., 12(6), 275-279.
- Di Stefano, A., Caramori, G., Oates, T., Capelli, A., Lusuardi, M., Gnemmi, I., Ioli. F., Chung. K. F., Donner, C. F., Barnes, P. J., Adcock. I. M. (2002). Increased expression of nuclear factor-κB in bronchial biopsies from smokers and patients with COPD. Eur. Respir. J., 20(3), 556-563.
- Fujita, R., Kiguchi, N., Ueda, H. (2007) LPA-mediated demyelination in ex vivo culture of dorsal root. Neurchem. Int., 50(2), 351-355.
- Isajevs, S., Pupure, J., Gordjušina, V., Kratovska, A., Taivans, I., Vīksna, L., Kalviņš, I., Kluša, V. (2007). Mildronate protects stavudine and lamivudine induced cardiotoxicity. Proc. Latvian Acad. Sci., Section B, 61(1-2), 26-32.
- Klusa, V., Pupure, J., Isajevs, S., Rumaks, J., Gordjushina, V., Kratovska, A., Taivans, I., Svirskis, S., Viksna, L., Kalvinsh, I. (2006). Protection of azidothymidine-induced cardiopathology in mice by mildronate, a mitochondria-targeted drug. Bas. Clin. Pharmacol. Toxicol., 99(4), 323-328.
- Lewis, W., Kohler, J. J., Hosseini, S. H., Haase, C. P., Copeland, W. C., Bienstock, R. J., Ludaway, T., McNaugh, J., Russ, R., Stuart, T., Santoianni, R. (2006). Antiretroviral nucleosides, deoxynucleotide carrier and mitochondrial DNA: Evidence supporting the DNA pol gamma hypothesis. AIDS, 20(5), 675-684.
- Petit, C., Pietri-Rouxel, F., Lesne, A., Leste-Lasserre, T., Mathez, D., Naviaux, R. K., Sonigo, P., Bouillaud, F., Leibowitch, J. (2005). Oxygen consumption by cultured human cells is impaired by a nucleoside analogue cocktail that inhibits mitochondrial DNA synthesis. Mitochondrion, 5(3), 154-161.
- Pupure, J., Fernandes, M. A. S., Santos, M. S., Moreno, A. J. M., Kalvinsh, I., Klusa, V., Oliveira, C. R. (2008). Mitochondria as the target for mildronate's protective effects in azidothymidine (AZT)-induced toxicity of isolated rat liver mitochondria. Cell Biochem. Funct., 26(5), 620-631.
- Pupure, J., Isajevs, S., Skapare, E., Rumaks, J., Svirskis, S., Kalvinsh, I., Klusa, V. (2010). Neuroprotective properties of mildronate, a mitochondria-targeted small molecule. Neurosci. Lett., 470(2), 100-105.
- Purevjav, E., Nelson, D. P., Varela, J. J., Jimenez, S., Kearney, D. L., Sanchez, X. V., DeFreitas, G., Carabello, B., Taylor, M. D., Vatta, M., Shearer, W. T., Towbin, J. A., Bowles, E. (2007). Myocardial Fas ligand expression increases susceptibility to AZT-induced cardiomyopathy. Cardiovasc. Toxicol., 7(4), 255-263.
- Scarsella, A., Coodley, G., Shalit, P., Anderson, R., Fisher, R. L., Liao, Q., Ross, L. L., Hernandez, J. E. (2002). Stavudine-associated peripheral neuropathy in zidovudine-naļve patients: Effect of stavudine exposure and antiretroviral experience. Adv. Ther., 19(1), 1-8.
- Tjolsen, A., Berge, O. G., Hunskaar, S., Rosland, J. H., Hole, K. (1992). The formalin test: An evaluation of the method. Pain, 51(1), 5-17.
- Ueda, H. (2008). Peripheral mechanisms of neuropathic pain—involvement of lysophosphatidic acid receptor-mediated demyelination. Mol. Pain, 4, 11.
- Weber, J., Mitchell, D., Kamerman, P. R. (2007) Oral administration of stavudine induces hyperalgesia without affecting activity in rats. Physiol. Behav., 92(5), 807-813.
- Yaksh, T. L. (1997) Preclinical models of nociception. In: Anesthesia: Biologic foundations. Yaksh, T. L., Lynch, C. III, Zapol, W.M, et al. (eds.). Philadelphia: Lippincott-Raven, pp. 685-718.